Mongodb Inc vs MiniMed Group Inc. Common Stock — how do they compare? Mongodb Inc trades at $383.41 (market cap $29.24B), while MiniMed Group Inc. Common Stock trades at $19.55 (market cap $5.57B). The key difference: Mongodb Inc is far larger — about 5.2× MiniMed Group Inc. Common Stock's market cap, and MiniMed Group Inc. Common Stock is more actively traded (23,336,073 versus 1,304,995). Which is the better fit depends on your goals — on Pluang, investors hold Mongodb Inc for 45 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| MDB | MMED | |
|---|---|---|
Market Cap | $29.24B | $5.57B |
Volume | 1,304,995 | 23,336,073 |
Sector | Technology | Health |
52-Week High | $472.29 | $23.84 |
52-Week Low | $225.95 | $10.80 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $26.86B | $5.37B |
Signals from Pluang's Aura AI — not financial advice
MongoDB (MDB) trades at $363.03, up 0.64% today, amid a bearish technical signal despite recent earnings beats. The stock faces headwinds with a high P/E of 511.31 and negative net income, though revenue growth remains strong, reaching $2.01B in 2025. Recent news highlights AI product launches and a CEO transition, with investor sentiment mixed following a sharp sell-off.
Outlook: Long-term growth potential exists with raised AI-focused targets, but high valuation and profitability challenges pose risks. Analyst consensus is bullish with an $456.76 price target, yet technical indicators and cash flow volatility warrant caution for near-term volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →